CMT Breakthrough: FDA Grants Orphan Drug Status to NMD670
January 7, 2025
NMD670, has been granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA)
News & Stories
News from the Hereditary Neuropathy Foundation: research updates, clinical trial progress, partnerships, and advocacy wins for the Charcot-Marie-Tooth community.
No matches for .
Showing 37 to 48 of 155 in News
-
-
Update on NMD Pharma Clinical Trial
November 19, 2024
-
How Does CMT Affect You?
September 18, 2024
Join the thousands of HNF volunteers who are fueling CMT research. The more you share, the more we'll learn. Complete your GRIN surveys today!
-
CMT Speak Out this Month with CMT (re)Post-its!
August 26, 2024
-
CMT Awareness Month 2024 - #CMTSPEAKOUT
August 21, 2024
-
HNF Awards the inaugural HNF Clinical Translation Fellowship
August 16, 2024
-
Research Opportunity: CMT-SORD
July 30, 2024
